Phase 1 Trial of Stem Cells Begins in MS
The hope is that mesenchymal stem cell-derived neural progenitors will repair the damage wreaked by MS
Following investigational new drug approval by the U.S. Food and Drug Administration on August 24...
Clinical Research, Drug Development
Editors' Pick
MS Cognitive Impairment Rates Lower Than Previously Reported
In a large MS group, cognitive impairment rates were unexpectedly low and few had severe impairment
In a large sample of persons with multiple sclerosis, rates of cognitive impairment were unexpectedly...
Clinical Research
Papers: 9 Aug 2013 - 16 Aug 2013
Plasma Osteopontin Levels: A New Marker for MS?
This study concluded that plasma osteopontin levels may be a marker for MS and neuromyelitis optica
Elevated plasma osteopontin levels could prove to be a valuable biomarker not only for multiple sclerosis but also...
Clinical Research
PUMA Protein May Underlie Oligodendroglial Cell Death in MS
A pro-apoptotic protein underlies oligodendroglial cell death in toxic demyelination and possibly in MS also
The PUMA protein (p53 upregulated modulator of apoptosis) underlies oligodendroglial cell death in...
Laboratory Research
MS and South hemisphere
Dear All, We are an NPO raising founds to open the first MS centre in South Africa, part of the idea is based on research that can take place in SA. the two basics idea behind are: 1.
Gut Bacteria Boost Anti-Inflammatory Immune Cells in Mice
Compounds they produce while breaking down dietary fiber increase the number and function of regulatory T cells
Common compounds made by gut microbes that break down dietary fiber appear to boost the...
Laboratory Research
Papers: 2 Aug 2013 - 9 Aug 2013
Pages
